|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Restructuring and other charges | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest and investment income | |||||
| Interest expense | |||||
| Change in fair value of purchase warrant liability | |||||
| Loss on purchase warrant liabilities | |||||
| Other expense | |||||
| Total other income (expense), net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Net unrealized (loss) gain on marketable securities | |||||
| Comprehensive loss | |||||
| Net loss per share - basic and diluted | |||||
| Weighted-average common stock outstanding - basic and diluted |
Loading...